tiprankstipranks
Trending News
More News >
Gain Therapeutics (GANX)
NASDAQ:GANX
US Market

Gain Therapeutics (GANX) Similar Stocks

Compare
389 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Gain Therapeutics
$4.14
$158.08M
153.99%
5 Buy
0 Hold
0 Sell
Strong Buy
Plus Therapeutics
$0.58
$98.95M
-48.65%
3 Buy
0 Hold
0 Sell
Strong Buy
ABVC BioPharma
$2.11
$68.53M
-12.64
322.00%
PMV Pharmaceuticals
$1.23
$65.45M
-0.78
-22.15%
4 Buy
0 Hold
0 Sell
Strong Buy
Prelude Therapeutics
$1.71
$99.61M
-0.99
113.75%
1 Buy
0 Hold
0 Sell
Moderate Buy
Immix Biopharma
$4.32
$186.69M
246.57%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
GANX
Gain Therapeutics
4.14
2.48
149.40%
PSTV
Plus Therapeutics
0.68
-0.49
-41.88%
ABVC
ABVC BioPharma
2.11
1.60
313.73%
PMVP
PMV Pharmaceuticals
1.23
-0.33
-21.15%
PRLD
Prelude Therapeutics
1.71
0.81
90.00%
IMMX
Immix Biopharma
7.07
5.12
262.56%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts